National Cancer Research Institute

Last updated

The National Cancer Research Institute (NCRI) is a UK-wide partnership between cancer research funders, which promotes collaboration in cancer research. Its member organizations work together to maximize the value and benefit of cancer research for the benefit of patients and the public. Rather than replace or duplicate any of the functions of its members, it seeks to add value through joint planning, coordination and collaboration.

Contents

History

In May 1999, the UK Prime Minister held a Downing Street Cancer Summit which led to the formation of the Cancer Research Funders Forum, bringing together the main government and charitable agencies that fund cancer research in the UK for the first time. [1]

Ian Gibson MP, a former cancer researcher from the University of East Anglia, [2] called for the creation of a UK National Cancer Institute in November 1998, modelled on the National Cancer Institute in the USA. [3] He used his influence as a member of the British House of Commons Science and Technology Committee to promote the idea and, in early 2000 the committee held an inquiry into the funding of cancer research in the UK which reported in July 2000, recommending "the creation of a new National Cancer Research Institute to set national research priorities and to co-ordinate and fund cancer research in the UK." [4]

Soon afterwards, in September 2000, the Department of Health published their first NHS Cancer Plan which announced that the Department would work with the Cancer Research Funders Forum to create a National Cancer Research Institute which would take a more proactive role in the strategic co-ordination of cancer research. [5]

The NCRI was formally launched on 1 April 2001.

On 26 June 2023, the NCRI announced that the NCRI was "winding down". [6] They published a letter from the NCRI's Chair, on behalf of the NCRI's Board of Trustees, outlining the decision. [7]

Activities

Current activities of the NCRI include:

The NCRI has also been responsible for:

The NCRI was, and remains, a leader in the introduction of patient/public involvement in clinical research. The NCRI Consumer Liaison Group was founded in 2000 and is administered by the National Cancer Research Network (NCRN). In the NCRI's early years the Chair of the Consumer Liaison Group was an NCRI Board member ex-officio. Since 2007 two patient/public Board appointments have been made following open advertisement.

Member organisations

See also

Related Research Articles

A radiation therapist, therapeutic radiographer or radiotherapist is an allied health professional who works in the field of radiation oncology. Radiation therapists plan and administer radiation treatments to cancer patients in most Western countries including the United Kingdom, Australia, most European countries, and Canada, where the minimum education requirement is often a baccalaureate degree or postgraduate degrees in radiation therapy. Radiation therapists can also prescribe medications and radiation, interpret tests results, perform follow ups, reviews, and provide consultations to cancer patients in the United Kingdom and Ontario, Canada . In the United States, radiation therapists have a lower educational requirement and often require postgraduate education and certification in order to plan treatments.

<span class="mw-page-title-main">Cancer Research UK</span> Cancer research and awareness charity

Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.

<span class="mw-page-title-main">Proton therapy</span> Medical Procedure

In medicine, proton therapy, or proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer. The chief advantage of proton therapy over other types of external beam radiotherapy is that the dose of protons is deposited over a narrow range of depth; hence in minimal entry, exit, or scattered radiation dose to healthy nearby tissues.

<span class="mw-page-title-main">Royal Marsden Hospital</span> Hospital in London, England

The Royal Marsden Hospital is a specialist National Health Service oncology hospital in London based at two sites in Brompton, in Kensington and Chelsea, and Belmont in Sutton. It is managed by The Royal Marsden NHS Foundation Trust and supported by The Royal Marsden Cancer Charity.

M. Krishnan Nair was an Indian oncologist. He was the founding director of the Regional Cancer Centre, Thiruvananthapuram, a director of the S.U.T. Institute of Oncology, and Trivandrum Cancer Center(TCC), part of SUT Royal Hospital in Thiruvananthapuram (Trivandrum) and a professor at the Amrita Institute of Medical Sciences & Research in Kochi. The Government of India awarded him the fourth highest civilian award of the Padma Shri in 2001 for his contributions in the cancer care field.

<span class="mw-page-title-main">European Organisation for Research and Treatment of Cancer</span> International nonprofit organization

The European Organisation for Research and Treatment of Cancer (EORTC) is a unique pan-European non-profit clinical cancer research organisation established in 1962 operating as an international association under Belgium law. It develops, conducts, coordinates and stimulates high-quality translational and clinical trial research to improve the survival and quality of life of cancer patients. This is achieved through the development of new drugs and other innovative approaches, and the testing of more effective therapeutic strategies, using currently approved drugs, surgery and/or radiotherapy in clinical trials conducted under the auspices of a vast network of clinical cancer researchers supported by 220 staff members based in Brussels. The EORTC has the expertise to conduct large and complex trials especially specific populations such as the older patient and rare tumours.

<span class="mw-page-title-main">Instituto Oncológico Nacional</span> Hospital in Panama, Panama

The National Oncologic Institute or ION is a specialized hospital for cancer treatment, located in Panama City, Panama. Between August 2000 and March 2001, patients receiving radiation treatment for prostate cancer and cancer of the cervix received lethal doses of radiation, resulting in eight fatalities.

The Penn State Cancer Institute is a cancer research center of the Penn State Milton S. Hershey Medical Center located in Hershey, Pennsylvania. The Institute provides clinical care, research, education, and community outreach services throughout central and eastern Pennsylvania. It serves approximately 3,000 inpatients and 22,500 outpatients annually.

<span class="mw-page-title-main">Regional Cancer Centre, Thiruvananthapuram</span> Medical research centre in India

The Regional Cancer Centre (RCC) at Thiruvananthapuram is a cancer care hospital and research centre. RCC was established in 1981 by the Government of Kerala and the Government of India. It is located in the Thiruvananthapuram Medical College campus in Thiruvananthapuram, the capital city of the state of Kerala. It was established as an expansion of the Radiation Therapy / Radiotherapy department of Medical College Trivandrum. It is a tertiary care center for the managements of all types of cancers. The clinics are mainly on Haematology, Lymphoreticular, soft tissue, bone, head and neck, breast, CNS, gynaecological, urinary, chest, gastro, paediatric oncology and thyroid.

University College London Hospitals NHS Foundation Trust (UCLH) is an NHS foundation trust based in London, United Kingdom. It comprises University College Hospital, University College Hospital at Westmoreland Street, the UCH Macmillan Cancer Centre, the Royal National ENT and Eastman Dental Hospitals, the Hospital for Tropical Diseases, the National Hospital for Neurology and Neurosurgery, the Royal London Hospital for Integrated Medicine and the Royal National Throat, Nose and Ear Hospital.

<span class="mw-page-title-main">James Lind Alliance</span>

The James Lind Alliance is a UK-based non-profit making initiative, established in 2004. It was established to bring patients, carers and clinicians together, in Priority Setting Partnerships, to identify and prioritise unanswered questions or evidence uncertainties that they agree are the most important. The intention is to ensure that those who fund health research are aware of what matters to patients, carers and clinicians who need to use the research in their everyday lives.

The National Institute for Health and Care Research (NIHR) is the British government's major funder of clinical, public health, social care and translational research. With a budget of over £1.2 billion in 2020–21, its mission is to "improve the health and wealth of the nation through research". The NIHR was established in 2006 under the government's Best Research for Best Health strategy, and is funded by the Department of Health and Social Care. As a research funder and research partner of the NHS, public health and social care, the NIHR complements the work of the Medical Research Council. NIHR focuses on translational research, clinical research and applied health and social care research.

<span class="mw-page-title-main">Biomedical sciences</span> Application of science to healthcare

Biomedical sciences are a set of sciences applying portions of natural science or formal science, or both, to develop knowledge, interventions, or technology that are of use in healthcare or public health. Such disciplines as medical microbiology, clinical virology, clinical epidemiology, genetic epidemiology, and biomedical engineering are medical sciences. In explaining physiological mechanisms operating in pathological processes, however, pathophysiology can be regarded as basic science.

The Cancer Drugs Fund (CDF) was introduced in England in 2011. It was established in order to provide a means by which National Health Service (NHS) patients in England could get cancer drugs rejected by National Institute for Health and Care Excellence because they were not cost effective. Its establishment was confirmed by the UK government's coalition agreement in 2010, and by the White Paper, Equity and excellence – Liberating the NHS.

Christopher M. Nutting is a British Professor of Clinical Oncology and medical consultant, specializing in head and neck cancers, who has helped develop Intensity-Modulated Radiotherapy (IMRT), an advanced form of Radiation therapy.

<span class="mw-page-title-main">Clatterbridge Cancer Centre NHS Foundation Trust</span> UK public sector healthcare provider

The Clatterbridge Cancer Centre is an NHS Foundation Trust, which specialises in the treatment of cancer. The centre is one of several specialist hospitals located within Merseyside; alongside Liverpool Heart and Chest Hospital, Alder Hey Children's Hospital, Liverpool Women's Hospital, and the Walton Centre.

<span class="mw-page-title-main">Pramod Kumar Julka</span>

Pramod Kumar Julka, is an Indian cancer specialist (oncologist), medical educationist and writer, known for performing the first peripheral blood stem cell transplant following high dose chemotherapy in Metastatic Breast Cancer in India. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine and medical education. The American Society of Clinical Oncology (ASCO) has awarded him by bestowing on him the honorary membership.

<span class="mw-page-title-main">Sam Ahmedzai</span> British care specialist

Professor Emeritus Sam H Ahmedzai FRCP, FRCPGlas, FFPMRCoA is a British supportive and palliative care specialist and an Honorary Consultant Physician in Palliative Medicine.

Deborah Watkins Bruner is an American researcher, clinical trialist, and academic. She is the senior vice president for research at Emory University. Her research focus is on patient reported outcomes, symptom management across cancer sites, sexuality after cancer treatment, and effectiveness of radiotherapy modalities. Bruner's research has been continually funding since 1998, with total funding of her research exceeding $180 million. She is ranked among the top five percent of all National Institutes of Health-funded investigators worldwide since 2012, according to the Blue Ridge Institute for Medical Research.

Mark Emberton is a urologist and prostate cancer research specialist using novel imaging techniques and minimally invasive treatments to improve diagnosis and treatment of prostate cancer.

References

  1. "Select Committee on Science and Technology Sixth Report". House of Commons. Retrieved 5 November 2014.
  2. "UEA Press Release". University of East Anglia. Retrieved 10 November 2014.
  3. "National cancer institute needed in Britain, MP says". THE. 13 February 1998. Retrieved 10 November 2014.
  4. "Cancer Research - A Fresh Look, Recommendations". publications.parliament.uk. Retrieved 3 February 2022.
  5. "National Cancer Plan". Archived from the original on 3 May 2012. Retrieved 10 November 2014.
  6. "NCRI is winding down after 22 remarkable years". 26 June 2023.
  7. https://www.ncri.org.uk/wp-content/uploads/NCRI-letter-26-June-2023.pdf [ bare URL PDF ]

Sources